The table below provides, for the periods indicated, information pertaining to the calculation of earnings per share, common stock equivalents, weighted-average number of antidilutive options, and shares issued (amounts in thousands):


	Three months ended April 30,				Six months ended April 30,
	2023		2022		2023		2022
Numerator:
Net income as reported	$	320,216	$	220,593	$	511,746	$	372,497

Denominator:
Basic weighted-average shares	111,214		117,839		111,306		119,418
Common stock equivalents (1)	970		1,086		954		1,473
Diluted weighted-average shares	112,184		118,925		112,260		120,891

Other information:

Weighted-average number of antidilutive options and restricted stock units (2)	168		214		334		209
Shares issued under stock incentive and employee stock purchase plans	103		17		1,437		424

(1) Common stock equivalents represent the dilutive effect of outstanding in-the-money stock options using the treasury stock method and shares expected to be issued upon the conversion of restricted stock units under our equity award programs.

(2) Weighted-average number of antidilutive options and restricted stock units are based upon the average closing price of our common stock on the New York Stock Exchange for the period.